David Colpman

Written By Jamison Wright

David Colpman has more than 30 years of biopharma business development and strategy experience, including as Head of Global Business Development at Shire Pharmaceuticals LLC where he led a series of strategic mergers, acquisitions, licensing and divestment programs. Mr. Colpman has also held senior business development roles with Novo Nordisk A/S, Boots Pharmaceuticals and GlaxoSmithKline Plc. Mr. Colpman currently serves on the boards of Orexo AB and HRA Pharma Ltd.

Jamison Wright https://jamisonwright.com
Previous

Tauhid Ali, Ph.D.
Next

Josh Distler, J.D.